Nanox

Nanox

NASDAQ:NNOX
Neve Ilan, Israel· Est.

Nanox provides an end-to-end medical imaging platform combining affordable 3D X-ray hardware with AI analytics to enable earlier disease detection and broader healthcare access.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

AI Company Overview

Nanox provides an end-to-end medical imaging platform combining affordable 3D X-ray hardware with AI analytics to enable earlier disease detection and broader healthcare access.

CardiovascularMetabolic DiseaseMusculoskeletal

Technology Platform

Proprietary silicon-based cold cathode field emission technology (Nanox.SOURCE) for digital X-ray generation, enabling multi-source 3D tomosynthesis systems, combined with AI algorithms for automated medical image analysis.

Opportunities

Significant growth potential in expanding access to medical imaging in underserved markets and outpatient settings, plus recurring revenue from AI software subscriptions and teleradiology services through their marketplace.

Risk Factors

Execution risk in scaling hardware manufacturing and deployment, competition from established imaging OEMs and AI startups, and dependency on healthcare provider adoption and reimbursement for AI-enhanced diagnostics.

Competitive Landscape

Competes with major imaging OEMs (GE, Siemens, Philips) on hardware and numerous AI imaging startups on software; differentiates via integrated low-cost hardware platform, proprietary cold cathode technology, and end-to-end ecosystem approach.